MHR
REGN icon

Matthew Hamilton Rosenberg’s Regeneron Pharmaceuticals REGN Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$45.5K Hold
60
– – 0.01% 457
2026
Q2 		$37.4K Hold
60
– – 0.01% 471
2026
Q1 		$46.4K Hold
60
– – 0.01% 430
2025
Q4 		$46.3K Hold
60
– – 0.01% 437
2025
Q3 		$33.7K Hold
60
– – 0.01% 472
2025
Q2 		$31.5K Hold
60
– – 0.01% 503
2025
Q1 		$38.1K Hold
60
– – 0.01% 465
2024
Q4 		$42.7K Sell
60
-6
-9% -$5.04K 0.01% 442
2024
Q3 		$69.4K Hold
66
– – 0.02% 377
2024
Q2 		$69.8K Hold
66
– – 0.02% 366
2024
Q1 		$64K Hold
66
– – 0.02% 388
2023
Q4 		$58K Buy
66
+6
+10% +$4.94K 0.02% 405
2023
Q3 		$49.4K Hold
60
– – 0.02% 423
2023
Q2 		$43.1K Hold
60
– – 0.01% 456
2023
Q1 		$49.3K Hold
60
– – 0.02% 467
2022
Q4 		$43.3K Hold
60
– – 0.01% 495
2022
Q3 		$41K Hold
60
– – 0.02% 487
2022
Q2 		$36K Hold
60
– – 0.01% 521
2022
Q1 		$42K Hold
60
– – 0.01% 481
2021
Q4 		$38K Buy
+60
New +$36.9K 0.01% 457

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Matthew Hamilton Rosenberg's REGN Position: Q3 2026 in Review

Matthew Hamilton Rosenberg held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 60 shares worth $45.5K. The position accounts for 0.01% of the portfolio, ranked #457.

Matthew Hamilton Rosenberg first reported a position in REGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $69.8K in Q2 2024. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Matthew Hamilton Rosenberg held 60 shares of Regeneron Pharmaceuticals worth $45.5K as of Q3 2026.
  • Matthew Hamilton Rosenberg left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #457 holding.
  • Matthew Hamilton Rosenberg first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • Matthew Hamilton Rosenberg's Regeneron Pharmaceuticals position peaked at $69.8K in Q2 2024.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.